Metraipolis › archive › dc_535986fcd8da

The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trial — Europe PMC PMID:42108271

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42108271
DOI
10.1038/s41591-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-11-02T13:13:24.023Z
SHA-256 of the archived text
61c8b6ad0d79954d0adfd7e2f646a89b78b87df0661bb9ced7074716c580c985
Stable URL of this page
https://metraipolis.com/documento/dc_535986fcd8da

How to cite

The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trial — Europe PMC PMID:42108271 — Europe PMC (en), https://europepmc.org/article/MED/42108271 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_535986fcd8da (Metraipolis archive dc_535986fcd8da, sha256 61c8b6ad0d79954d0adfd7e2f646a89b78b87df0661bb9ced7074716c580c985)
BibTeX
@misc{dc535986fcd8da,
  title = {The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trial — Europe PMC PMID:42108271},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42108271},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_535986fcd8da; sha256 61c8b6ad0d79954d0adfd7e2f646a89b78b87df0661bb9ced7074716c580c985},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42108271. Agents can read the archived copy with the MCP tool read_document.